ARCA biopharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$5,339,000 over the previous period. Total operating expenses were $7,296,000.
Profit Margin
| 2014 | 0 | -9.68M | |
|---|---|---|---|
| 2015 | 0 | -11.44M | |
| 2016 | 0 | -16.46M | |
| 2017 | 0 | -18.49M | |
| 2018 | 0 | -7.93M | |
| 2019 | 0 | -5.48M | |
| 2020 | 0 | -9.73M | |
| 2021 | 0 | -19.23M | |
| 2022 | 0 | -9.25M | |
| 2023 | 0 | -5.33M |
ABIO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 111K | 114K | 91K | 93K | 89K | 22K | 27K | 24K | 0 | 0 |
Gross profit | -111K | -114K | -91K | -93K | -89K | -22K | -27K | -24K | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 1.01M | 4.74M | 13.83M | 4.99M | 1.83M | 4.23M | 14.07M | 12.34M | 7.06M | 5.62M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 7.29M | 10.59M | 19.33M | 9.76M | 5.81M | 8.11M | 18.71M | 16.61M | 11.45M | 9.69M |
Operating income | -7.29M | -10.59M | -19.33M | -9.76M | -5.81M | -8.11M | -18.71M | -16.61M | -11.45M | -9.69M |
Other income (expenses), net | 1.95M | 670K | 13K | 19K | 165K | 154K | 161K | 169K | 10K | 4K |
Income before tax | -5.33M | -9.92M | -19.32M | -9.74M | -5.64M | -7.96M | -18.55M | -16.44M | -11.44M | -9.68M |
Income tax expense | -111K | -670K | -91K | -9K | -167K | -31K | -61K | 188K | 14K | 7K |
Net income | -5.33M | -9.25M | -19.23M | -9.73M | -5.48M | -7.93M | -18.49M | -16.46M | -11.44M | -9.68M |
Earnings per share | ||||||||||
Basic EPS | -0.37 | -0.64 | -1.38 | -2.07 | -4.15 | -10.31 | -31.91 | -32.68 | -32.76 | -59.55 |
Diluted EPS | -0.37 | -0.64 | -1.38 | -2.07 | -4.15 | -10.31 | -31.91 | -32.68 | -32.76 | -59.55 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |